Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SmartZyme BioPharma
Israelprnewswire.com ↗
- Ownership
- Private
- Employees
- ~49
- Development stage
- Preclinical
01
Overview
SmartZyme BioPharma develops a next-generation glucose-sensing enzyme designed to improve the performance and reduce the cost of continuous glucose monitors. Their proprietary enzyme enables direct electron transfer without mediators, potentially reducing device costs by up to 90% and improving accuracy at low glucose levels. As of their last updates, they were validating their technology in multi-day animal studies with plans to move into human clinical trials. The company previously had a broader protein engineering platform ("PROVOLUTION™"), which was spun off into Carnot BioSciences in partnership with HemoShear Therapeutics for rare metabolic disease drug discovery.[5][9]
- Therapeutic areas
- Endocrinology
- Modalities
- Enzymes (specifically glucose-sensing enzymes)Protein engineering/biologics (historically; platform spun out in Carnot BioSciences)
- Industry
- Metabolite Diagnostics
02
Partnerships
OrbiMed Advisors (investor/portfolio company)[5][7]Historical R&D collaboration via spinout with HemoShear Therapeutics through Carnot BioSciences[5][9]
Beyond the preview
Go deeper on SmartZyme BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SmartZyme BioPharma.